280 related articles for article (PubMed ID: 9362422)
21. [High PTHrP level induced hypercalcemia and acute renal failure in a multiple myeloma patient].
Saito O; Kurosu M; Ando Y; Kusano E; Asano Y
Nihon Jinzo Gakkai Shi; 2000 Jan; 42(1):41-6. PubMed ID: 10737013
[TBL] [Abstract][Full Text] [Related]
22. A novel mature B-cell line (DOBIL-6) producing both parathyroid hormone-related protein and interleukin-6 from a myeloma patient presenting with hypercalcaemia.
Ohmori M; Nagai M; Fujita M; Dobashi H; Tasaka T; Yamaoka G; Kawanishi K; Taniwaki M; Takahara J
Br J Haematol; 1998 Jun; 101(4):688-93. PubMed ID: 9674742
[TBL] [Abstract][Full Text] [Related]
23. Tumor necrosis factor enhances parathyroid hormone-related protein-induced hypercalcemia and bone resorption without inhibiting bone formation in vivo.
Uy HL; Mundy GR; Boyce BF; Story BM; Dunstan CR; Yin JJ; Roodman GD; Guise TA
Cancer Res; 1997 Aug; 57(15):3194-9. PubMed ID: 9242449
[TBL] [Abstract][Full Text] [Related]
24. Mechanisms of osteolytic bone destruction.
Mundy GR
Bone; 1991; 12 Suppl 1():S1-6. PubMed ID: 1954046
[TBL] [Abstract][Full Text] [Related]
25. Production of lymphotoxin, a bone-resorbing cytokine, by cultured human myeloma cells.
Garrett IR; Durie BG; Nedwin GE; Gillespie A; Bringman T; Sabatini M; Bertolini DR; Mundy GR
N Engl J Med; 1987 Aug; 317(9):526-32. PubMed ID: 3497347
[TBL] [Abstract][Full Text] [Related]
26. [Serum levels of carboxyterminal propeptide of type I procollagen (PICP), cross-linked carboxyterminal telopeptide region of type I collagen (ICTP) and carboxyterminal parathyroid hormone-related protein (C-PTHrP) in hematological malignancies with bone lesions and hypercalcemia].
Tanaka K; Shiraishi K; Sakamoto A; Jojima H; Masuchi K; Okubo Y; Tanaka M; Fuzimatsu Y; Fukahori S; Osabe S; Imamura Y; Honda J; Oizumi K
Rinsho Ketsueki; 1998 Apr; 39(4):273-80. PubMed ID: 9597894
[TBL] [Abstract][Full Text] [Related]
27. Primary bone adult T cell lymphoma with multiple skeletal lesions and debilitating painful osteolysis: a case report.
Kato H; Koga M; Kobayashi H; Maki H; Ikemura M; Kurokawa M; Nangaku M; Makita N; Ito N
Osteoporos Int; 2021 May; 32(5):1013-1017. PubMed ID: 33128574
[TBL] [Abstract][Full Text] [Related]
28. The use of clodronate in multiple myeloma.
Delmas PD
Bone; 1991; 12 Suppl 1():S31-4. PubMed ID: 1835398
[TBL] [Abstract][Full Text] [Related]
29. An in vivo model of human multiple myeloma bone disease.
Alsina M; Boyce BF; Mundy GR; Roodman GD
Stem Cells; 1995 Aug; 13 Suppl 2():48-50. PubMed ID: 8520511
[TBL] [Abstract][Full Text] [Related]
30. Ascites sarcoma 180, a tumor associated with hypercalcemia, secretes potent bone-resorbing factors including transforming growth factor alpha, interleukin-1 alpha and interleukin-6.
Suzuki K; Yamada S
Bone Miner; 1994 Dec; 27(3):219-33. PubMed ID: 7696888
[TBL] [Abstract][Full Text] [Related]
31. New insights in myeloma-induced osteolysis.
Barillé-Nion S; Bataille R
Leuk Lymphoma; 2003 Sep; 44(9):1463-7. PubMed ID: 14565645
[TBL] [Abstract][Full Text] [Related]
32. Pathogenesis of myeloma bone disease.
Roodman GD
Leukemia; 2009 Mar; 23(3):435-41. PubMed ID: 19039321
[TBL] [Abstract][Full Text] [Related]
33. Therapeutic efficacy of a soluble receptor activator of nuclear factor kappaB-IgG Fc fusion protein in suppressing bone resorption and hypercalcemia in a model of humoral hypercalcemia of malignancy.
Oyajobi BO; Anderson DM; Traianedes K; Williams PJ; Yoneda T; Mundy GR
Cancer Res; 2001 Mar; 61(6):2572-8. PubMed ID: 11289133
[TBL] [Abstract][Full Text] [Related]
34. Parathyroid hormone-related protein-induced hypercalcemia in SCID mice engrafted with adult T-cell leukemia cells.
Takaori-Kondo A; Imada K; Yamamoto I; Kunitomi A; Numata Y; Sawada H; Uchiyama T
Blood; 1998 Jun; 91(12):4747-51. PubMed ID: 9616173
[TBL] [Abstract][Full Text] [Related]
35. Parathyroid hormone-related protein promotes bone loss in T-cell leukemia as well as in solid tumors.
Kohart NA; Elshafae SM; Demirer AA; Dirksen WP; Breitbach JT; Shu ST; Xiang J; Weilbaecher KN; Rosol TJ
Leuk Lymphoma; 2020 Feb; 61(2):409-419. PubMed ID: 31592701
[TBL] [Abstract][Full Text] [Related]
36. Expression of parathyroid hormone-related protein (PTHrP) in multiple myeloma.
Kitazawa R; Kitazawa S; Kajimoto K; Sowa H; Sugimoto T; Matsui T; Chihara K; Maeda S
Pathol Int; 2002 Jan; 52(1):63-8. PubMed ID: 11940209
[TBL] [Abstract][Full Text] [Related]
37. Expression of tumor invasion factors determines systemic engraftment and induction of humoral hypercalcemia in a mouse model of adult T-cell leukemia.
Parrula C; Zimmerman B; Nadella P; Shu S; Rosol T; Fernandez S; Lairmore M; Niewiesk S
Vet Pathol; 2009 Sep; 46(5):1003-14. PubMed ID: 19429977
[TBL] [Abstract][Full Text] [Related]
38. Hematological malignancies and the bone (myeloma excluded).
Roux S; Mariette X
Joint Bone Spine; 2000; 67(4):264-71. PubMed ID: 10963072
[TBL] [Abstract][Full Text] [Related]
39. Interleukin-6 is the central tumor growth factor in vitro and in vivo in multiple myeloma.
Klein B; Zhang XG; Jourdan M; Boiron JM; Portier M; Lu ZY; Wijdenes J; Brochier J; Bataille R
Eur Cytokine Netw; 1990; 1(4):193-201. PubMed ID: 2104241
[TBL] [Abstract][Full Text] [Related]
40. p38 MAPK in myeloma cells regulates osteoclast and osteoblast activity and induces bone destruction.
He J; Liu Z; Zheng Y; Qian J; Li H; Lu Y; Xu J; Hong B; Zhang M; Lin P; Cai Z; Orlowski RZ; Kwak LW; Yi Q; Yang J
Cancer Res; 2012 Dec; 72(24):6393-402. PubMed ID: 23066034
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
